Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Common Equity (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Common Equity for 17 consecutive years, with $18.5 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 13.09% to $18.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.5 billion through Dec 2025, up 13.09% year-over-year, with the annual reading at $18.5 billion for FY2025, 13.09% up from the prior year.
  • Common Equity for Q4 2025 was $18.5 billion at Bristol Myers Squibb, down from $18.6 billion in the prior quarter.
  • The five-year high for Common Equity was $26.6 billion in Q1 2023, with the low at -$36.4 billion in Q3 2022.
  • Average Common Equity over 5 years is $1.3 billion, with a median of $60.5 million recorded in 2021.
  • The sharpest move saw Common Equity tumbled 2456.95% in 2022, then surged 29814.81% in 2025.
  • Over 5 years, Common Equity stood at $60.0 million in 2021, then surged by 386.67% to $292.0 million in 2022, then changed by 0.0% to $292.0 million in 2023, then soared by 5494.18% to $16.3 billion in 2024, then grew by 13.09% to $18.5 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $18.5 billion, $18.6 billion, and $16.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.